BIOMAT Database Logo BIOMAT Database Logo

[Drug therapy of acromegaly]. 1977

H Hosoki

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Hosoki
[Drug therapy of acromegaly].
January 2004, Krankenpflege Journal,
H Hosoki
[Drug therapy for acromegaly].
April 2005, Problemy endokrinologii,
H Hosoki
[Drug therapy for acromegaly].
September 2013, Orvosi hetilap,
H Hosoki
[Drug therapy of hyperprolactinemia and acromegaly].
January 1978, Acta medica Austriaca,
H Hosoki
[Drug therapy of hyperprolactinemia and acromegaly].
May 1983, Schweizerische medizinische Wochenschrift,
H Hosoki
Drug insight: Primary medical therapy of acromegaly.
February 2006, Nature clinical practice. Endocrinology & metabolism,
H Hosoki
[Drug therapy of hyperprolactinemia, acromegaly and Cushing syndrome].
November 1983, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
H Hosoki
[Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy].
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Hosoki
Therapy of acromegaly.
March 1971, The New England journal of medicine,
H Hosoki
[Therapy of acromegaly].
March 1973, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!